🤑 It doesn’t get more affordable. Grab this 60% OFF Black Friday offer before it disappears…CLAIM SALE

WADA defends TUE system after leaked data

Published 28/09/2016, 15:28
© Reuters. A woman walks into the head offices of WADA in Montreal

SEVRES, France (Reuters) - The World Anti-Doping Agency (WADA) on Wednesday defended the Therapeutic Use Exemption (TUE) system after some athletes' confidential medical data was leaked by a group of Russian hackers, shedding light on potential abuse.

A group identified as APT28 and Fancy Bear by U.S. cyber-security researchers revealed TUEs for leading athletes including Tour de France cycling champions Chris Froome and Bradley Wiggins and tennis grand slam winners Serena Williams and Rafa Nadal.

TUEs allow athletes to take banned substances for verified medical needs and are signed off by sports federations.

"TUEs fall under international standards... They are scrutinised by the medical community," WADA Senior Science Director Olivier Rabin told a joint news conference with International Bureau of Weights and Measures (BIPM).

"WADA can review and appeal the TUEs. If there is a risk of abuse, WADA has the right to overturn," Rabin said, adding that the leaked information had only very limited value.

Suggestions that the number of TUEs had dramatically increased in the past year are false, added Valerie Fourneyron, the head Health, Medicine and Research at WADA.

"(The number seems to have increased) because more and more national anti-doping agencies have put the TUEs into ADAMS (Anti-Doping Administration and Management System)," she said.

"Several countries in the past year have put all their TUEs on ADAMS - Italy, France, Tunisia, Malaysia."

Team Sky boss Dave Brailsford defended Wiggins on Monday, saying the 2012 Tour de France champion's TUEs were "not being used to enhance performance".

A leading expert, however, said on Wednesday that the explanations of Wiggins and Brailsford were "shaky".

"There is no logic in injecting yourself with (the corticosteroid) Kenacort before the start of a grand tour," Dr Armand Megret, an expert for the Movement for Credible Cycling, told French sports daily L'Equipe.

"It does not make sense that such a champion with such team with such an organised staff can take corticoids so casually."

The data revealed the Briton was given permission to take triamcinolone before the 2011 and 2012 Tours as well as the 2013 Tour of Italy.

© Reuters. A woman walks into the head offices of WADA in Montreal

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.